BOSTON, May 10, 2017 /PRNewswire/ — Intrinsic Therapeutics, Inc. a medical device company that has developed a product to improve outcomes in lumbar discectomy patients, announced today that it recently closed a $49 million round of financing.  The financing included a $28 million equity round co-led by New Enterprise Associates […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone